LIANBIO-ADR (LIAN) Stock Earnings & Estimates
NASDAQ:LIAN - US53000N1081 - ADR
0.319 USD
-0.03 (-8.28%)
0.32 USD
+0 (+0.31%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A -100.00% | N/A | N/A | N/A 42.10% | N/A 28.20% | N/A 21.71% | |||||
| EBITDA YoY % growth | -24.34M | -134.79M -453.78% | -195.04M -44.70% | -124.34M 36.25% | N/A 297.18% | N/A -173.11% | N/A 8.64% | N/A 174.41% | N/A 155.95% | N/A 25.42% | N/A 23.35% | N/A 18.62% | |
| EBIT YoY % growth | -24.34M | -134.87M -454.11% | -195.57M -45.01% | -125.35M 35.91% | N/A 18.38% | N/A -13.66% | N/A -42.31% | N/A 60.55% | N/A 474.02% | N/A 32.45% | N/A 28.24% | N/A 21.67% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.02 70.08% | N/A 16.00% | N/A -1.79% | N/A 50.88% | N/A -16.67% | N/A 375.51% | N/A 32.59% | N/A 34.64% | N/A 27.39% |
All data in USD
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.32 -86.00% | -0.09 58.27% | -0.09 54.10% | -0.09 58.27% | -0.09 70.97% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -55.437M -96.31% | -28.733M -12.02% | -28.723M -17.81% | -28.774M -13.64% | -28.744M 48.15% |
| EBIT Q2Q % growth | -41.662M -42.43% | -12.75M 50.90% | -12.75M 49.08% | -12.75M 51.52% | -12.75M 69.40% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2023 Q2Q % growth | -0.22 -10.00% | -0.34 | 0.12 | 34.64% |
| Q2 2023 Q2Q % growth | -0.20 48.72% | -0.29 | 0.09 | 31.20% |
| Q1 2023 Q2Q % growth | -0.22 15.38% | -0.28 | 0.06 | 20.85% |
| Q4 2022 Q2Q % growth | -0.17 39.29% | -0.28 | 0.11 | 38.84% |
| Q3 2022 Q2Q % growth | -0.20 68.25% | -0.40 | 0.20 | 50.04% |
| Q2 2022 Q2Q % growth | -0.39 | -0.28 | -0.11 | -39.04% |
| Q1 2022 Q2Q % growth | -0.26 | -0.30 | 0.04 | 14.32% |
| Q4 2021 Q2Q % growth | -0.28 | -0.73 | 0.45 | 61.61% |
| Q3 2021 Q2Q % growth | -0.63 | -0.59 | -0.04 | -7.42% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 5.1M | -5.1M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 28.46% | 21.86% | 21.86% |
| Revenue | N/A | N/A | N/A | N/A |